Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
KUAISHOU-W
01024
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 78.93%10.9M | -21.14%11.41M | -23.76%6.09M | 66.16%14.46M | 82.16%10.79M | 103.33%7.99M | 19.86%2.28M | -32.58%8.71M | -45.69%5.93M | -49.07%3.93M |
| Operating income | 78.93%10.9M | -21.14%11.41M | -23.76%6.09M | 66.16%14.46M | 82.16%10.79M | 103.33%7.99M | 19.86%2.28M | -32.58%8.71M | -45.69%5.93M | -49.07%3.93M |
| Operating expenses | ||||||||||
| Gross profit | ||||||||||
| Administrative expenses | 17.67%-13.59M | 2.54%-28.22M | -6.93%-16.51M | 7.99%-28.96M | 2.60%-22.25M | 0.65%-15.44M | 12.26%-6.9M | -4.64%-31.47M | 0.18%-22.85M | 3.56%-15.54M |
| Revaluation surplus | 114.31%1.41M | -206.84%-2.69M | -208.64%-9.86M | -39.12%2.52M | 39.20%-4.12M | 74.04%-3.19M | 87.70%-1.74M | -82.14%4.13M | -1,350.75%-6.78M | -41,106.67%-12.3M |
| -Changes in the fair value of financial assets | 114.31%1.41M | -206.84%-2.69M | -208.64%-9.86M | -39.12%2.52M | 39.20%-4.12M | 74.04%-3.19M | 87.70%-1.74M | -82.14%4.13M | -1,350.75%-6.78M | -41,106.67%-12.3M |
| Operating interest expense | ---- | ---- | ---- | ---- | -483.75%-467K | -557.50%-263K | -445.45%-120K | ---- | 94.71%-80K | 96.67%-40K |
| Special items of operating profit | 120.92%2.36M | -3.28%2.86M | 7.46%1.07M | 119.12%2.96M | -13.56%2.08M | -24.79%992K | 14.90%401K | -918.64%-15.46M | 83.07%2.41M | 12.83%1.32M |
| Operating profit | 105.63%1.08M | -84.47%-16.64M | -93.82%-19.2M | 73.54%-9.02M | 34.65%-13.96M | 56.22%-9.91M | 69.22%-6.07M | -308.93%-34.09M | -69.02%-21.37M | -169.61%-22.63M |
| Financing cost | -140.78%-862K | -35.20%-918K | ---358K | -265.05%-679K | ---- | ---- | ---- | ---186K | ---- | ---- |
| Share of profits of associates | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -2.17%-94K | ---94K | ---94K |
| Earning before tax | 101.12%219K | -81.02%-17.56M | -97.44%-19.56M | 71.78%-9.7M | 34.94%-13.96M | 56.40%-9.91M | 69.37%-6.07M | -307.78%-34.37M | -69.77%-21.46M | -170.73%-22.72M |
| Tax | ---- | -99.28%1K | ---- | -45.24%138K | ---- | ---- | ---- | 156.63%252K | ---- | ---- |
| After-tax profit from continuing operations | 101.12%219K | -83.62%-17.56M | -97.44%-19.56M | 71.97%-9.56M | 34.94%-13.96M | 56.40%-9.91M | 69.37%-6.07M | -284.49%-34.12M | -69.77%-21.46M | -170.73%-22.72M |
| Earning after tax | 101.12%219K | -83.62%-17.56M | -97.44%-19.56M | 71.97%-9.56M | 34.94%-13.96M | 56.40%-9.91M | 69.37%-6.07M | -284.49%-34.12M | -69.77%-21.46M | -170.73%-22.72M |
| Profit attributable to shareholders | 101.12%219K | -83.62%-17.56M | -97.44%-19.56M | 71.97%-9.56M | 34.94%-13.96M | 56.40%-9.91M | 69.37%-6.07M | -284.49%-34.12M | -69.77%-21.46M | -170.73%-22.72M |
| Basic earnings per share | 101.13%0.0023 | -83.63%-0.1829 | -97.38%-0.2037 | 67.33%-0.0996 | 20.11%-0.1454 | 45.83%-0.1032 | 61.91%-0.0633 | -242.20%-0.3049 | -1,238.24%-0.182 | -1,970.65%-0.1905 |
| Diluted earnings per share | 101.13%0.0023 | -83.63%-0.1829 | -97.38%-0.2037 | 67.33%-0.0996 | 20.11%-0.1454 | 45.83%-0.1032 | 61.91%-0.0633 | -242.20%-0.3049 | -1,238.24%-0.182 | -1,970.65%-0.1905 |
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- |
| Auditor | -- | Guowei Certified Public Accountants Co., Ltd. | -- | Guowei Certified Public Accountants Co., Ltd. | -- | -- | -- | Guowei Certified Public Accountants Co., Ltd. | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.